Printer Friendly

Printed from http://www.researchandmarkets.com/reports/2081762

Aptalis Pharma Inc. - Strategic SWOT Analysis Review

Description:

Summary

Aptalis Pharma Inc. (Aptalis), formerly Axcan Intermediate Holdings, Inc., is a specialty pharmaceutical company that carries out the development and commercialization of drugs for the treatment of gastrointestinal disorders and cystic fibrosis. Some of its products include Zenpep, Canasa, Carafate, Pylera, Rectiv, Viokace, Ultresa Lacteol, Delursan, Panzytrat, and Salofalk. Furthermore, it formulates and develops enhanced pharmaceutical and bio-pharmaceutical products using its proprietary technology platforms that include custom release profiles, bioavailability enhancement of poorly soluble drugs, and taste-masking/orally disintegrating tablet (ODT) formulations.

Aptalis Pharma Inc. Key Recent Developments

Sep 17, 2012: Aptalis Pharma To Create 75 New JobsnFeb 10, 2012: Aptalis Pharma Reports Revenue Of $152.4m In Q1 Fiscal 2012

Our Aptalis Pharma Inc. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Our summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with Our detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Contents:

List of Tables
List of Figures
Section 1 - About the Company
Aptalis Pharma Inc. - Key Facts
Aptalis Pharma Inc. - Key Employees
Aptalis Pharma Inc. - Key Employee Biographies
Aptalis Pharma Inc. - Major Products and Services
Aptalis Pharma Inc. - Pharmaceutical Pipeline Products Data
Aptalis Pharma Inc., Pipeline Products by Therapy Area
Aptalis Pharma Inc., Pipeline Products by Development Phase
Aptalis Pharma Inc. - History
Aptalis Pharma Inc. - Company Statement
Aptalis Pharma Inc. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Aptalis Pharma Inc. - Business Description
Aptalis Pharma Inc. - Corporate Strategy
Aptalis Pharma Inc. - SWOT Analysis
SWOT Analysis - Overview
Aptalis Pharma Inc. - Strengths
Strength - Broad Product Portfolio
Strength - Focused R&D Activities
Strength - Proprietary Pharmaceutical Technologies
Aptalis Pharma Inc. - Weaknesses
Weakness - Geographical Concentration: the US
Aptalis Pharma Inc. - Opportunities
Opportunity - Strategic Alliances
Opportunity - Market Potential - Gastrointestinal Disorders
Opportunity - Changing Demographics
Aptalis Pharma Inc. - Threats
Threat - Dependency on Wholesale Distributors
Threat - Stringent Government Regulations
Threat - Launch of Generics
Aptalis Pharma Inc. - Key Competitors
Section 3 – Company’s Lifesciences Financial Deals and Alliances
Aptalis Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Aptalis Pharma Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Aptalis Pharma Inc., Recent Deals Summary
Section 4 – Company’s Recent Developments
Aptalis Pharma Inc., Recent Developments
Sep 17, 2012: Aptalis Pharma To Create 75 New Jobs
Feb 10, 2012: Aptalis Pharma Reports Revenue Of $152.4m In Q1 Fiscal 2012
Section 5 – Appendix
Methodology
About Us
Contact Us
Disclaimer

List of Tables
Aptalis Pharma Inc., Key Facts
Aptalis Pharma Inc., Key Employees
Aptalis Pharma Inc., Key Employee Biographies
Aptalis Pharma Inc., Major Products and Services
Aptalis Pharma Inc., Number of Pipeline Products by Therapy Area
Aptalis Pharma Inc., Number of Pipeline Products by Development Stage
Aptalis Pharma Inc., Pipeline Products By Therapy Area and Development Phase
Aptalis Pharma Inc., History
Aptalis Pharma Inc., Other Locations
Aptalis Pharma Inc., Subsidiaries
Aptalis Pharma Inc., Key Competitors
Aptalis Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Aptalis Pharma Inc., Pharmaceuticals & Healthcare, Deals By Type, 2007 to YTD 2013
Aptalis Pharma Inc., Recent Deals Summary

List of Figures
Aptalis Pharma Inc., Pipeline Products by Therapy Area
Aptalis Pharma Inc., Pipeline Products by Development Phase
Aptalis Pharma Inc., Pharmaceuticals & Healthcare, Deals By Year, 2007 to YTD 2013
Aptalis Pharma Inc., Pharmaceuticals & Healthcare, Deals by Type, 2007 to YTD 2013

Ordering:

Order Online - visit http://www.researchandmarkets.com/reports/1582661

Order by Fax - using the order form below

Order By Post - print the order form below and send to

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Page 1 of 2

Printed Sunday, May 19, 2013
10:46:58 PM

Fax order form

To place a fax order simply print this form, fill in and fax the completed form to the number below. If you have any questions please email help@researchandmarkets.net

Order information

Please verify that the product information is correct and select the format you require.

Product name

Aptalis Pharma Inc. - Strategic SWOT Analysis Review

Web Address

http://www.researchandmarkets.com/reports/2081762

Office Code

OC8DIQSRTPRQPY

Report Formats

Please enter the quantity of the report format you require.

Format	Quantity	Price
Electronic (PDF) - Single User		EURO€ 96.00
Electronic (PDF) - Site License		EURO€ 192.00
Electronic (PDF) - Enterprisewide		EURO€ 288.00

Contact information

Please enter all the information below in block capitals.

                Title:
            
                    Mr
                    
                    Mrs
                    
                    Dr
                    
                    Miss
                    
                    Ms
                    
                    Prof
                    
                First Name:
            
                Last Name:
                
                Email Address:
            
                Job Title:
            
                Organisation:
            
                Address:
            
                City:
            
                Postal / Zip Code:	
            
                Country:	
            
                Phone Number:	
            
                Fax Number:

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Page 2 of 2

Printed Sunday, May 19, 2013
10:46:58 PM

Payment information

Please indicate the payment method you would like to use by selecting the appropriate box.

Pay by Credit Card:

American Express

Diners Club

Master Card

Visa

Cardholder's Name:

Cardholder's Signature:

Expiry Date:

Card Number:

CVV Security Code:

Issue date:

(Diners Club only)

Pay by Check:

Please post the check, accompanied by this form, to:

Research and Markets,
Guinness Centre,
Taylors Lane,
Dublin 8,
Ireland.

Pay by Wire Transfer:

Please transfer funds to:

Account Number:

83313083

Sort Code:

98-53-30

Swift Code:

ULSBIE2D

IBAN Number:

IE78ULSB98533083313083

Bank Address:

Ulster Bank,
27-35 Main Street
Blackrock,
Co. Dublin
Ireland.

If you have a Marketing Code please enter it below:

Marketing Code:

Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Printer Friendly

Aptalis Pharma Inc. - Strategic SWOT Analysis Review

Fax order form

Order information

Product name

Web Address

Office Code

Report Formats

Contact information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Payment information

Please fax this form to: (646) 607-1907 or (646) 964-6609 (from USA) +353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)

Please fax this form to:
(646) 607-1907 or (646) 964-6609 (from USA)
+353-1-481-1716 or +353-1-653-1571 (from Rest of World)